EUVIMEDEUVIMED entdecken
Crossref

Efficacy and Safety of Regulatory Vascular Polypeptides in Chronic Venous Diseases of the Lower Extremities: Results of a Randomized Placebo-Controlled Study

I.A. Suchkov, A.A. Kamaev, A.V. Chupin, S.V. Sapelkin, A.G. Burenin

Journal of Venous Disorders · 30.04.2026 · 20 (2) · 89

DOI: 10.17116/flebo20262002189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Venous Disorders, erschienen am 30.04.2026. Verfasst von I.A. Suchkov und 4 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the efficacy and safety of a therapeutic agent derived from regulatory polypeptides sourced from bovine vascular tissue in combination therapy for patients diagnosed with chronic venous diseases (CVD) in the lower extremities. Material and methods. This multicenter, randomized, double-blind, placebo-controlled trial involved 190 patients with CVD, randomly assigned to two groups. Group 1 received a combination of vascular polypeptides and troxerutin (n=95), while Group 2 received placebo with troxerutin (n=95). The total duration of the observation period extended to 137 days. This period included five scheduled visits: Visit 1 at the start of therapy; Visit 2 after 14±2 days of treatment; Visit 3 at the end of the treatment (35±2 days); Visit 4 30±3 days after the end of the treatment; and Visit 5 90±5 days after the end of the treatment. Efficacy was evaluated using the Venous Clinical Severity Score (VCSS), and pain and discomfort were quantified using the Visual Analog Scale (VAS). Quality-of-life outcomes were measured using the CIVIQ-20 questionnaire, and changes in malleolar circumference were recorded. Safety was assessed by the frequency and types of adverse events.

Results

At Visit 4, the mean VCSS in Group 1 was 2.33±1.31, compared to 3.24±1.62 in Group 2, resulting in a mean difference of –0.92 (95% CI from –1.34 to –0.50; p

Zitieren

APA

Suchkov, I., Kamaev, A., Chupin, A., Sapelkin, S., & Burenin, A. (2026). Efficacy and Safety of Regulatory Vascular Polypeptides in Chronic Venous Diseases of the Lower Extremities: Results of a Randomized Placebo-Controlled Study. Journal of Venous Disorders, 20(2), 89. https://doi.org/10.17116/flebo20262002189

Vancouver

Suchkov I, Kamaev A, Chupin A, Sapelkin S, Burenin A. Efficacy and Safety of Regulatory Vascular Polypeptides in Chronic Venous Diseases of the Lower Extremities: Results of a Randomized Placebo-Controlled Study. Journal of Venous Disorders. 2026;20(2):89. doi:10.17116/flebo20262002189

BibTeX
@article{Suchkov2026,
  author = {Suchkov, I.A. and Kamaev, A.A. and Chupin, A.V. and Sapelkin, S.V. and Burenin, A.G.},
  title = {Efficacy and Safety of Regulatory Vascular Polypeptides in Chronic Venous Diseases of the Lower Extremities: Results of a Randomized Placebo-Controlled Study},
  journal = {Journal of Venous Disorders},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {89},
  doi = {10.17116/flebo20262002189}
}
Kostenlos starten →